APA

Heintel D., Skrabs C., Hauswirth A., Eigenberger K., Einberger C., Raderer M., Sperr W. R., Knöbl P., Müllauer L., Uffmann M., Dieckmann K., Gaiger A. & Jäger U. (20100111). Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. : Annals of hematology.

Chicago

Heintel Daniel, Skrabs Cathrin, Hauswirth Alexander, Eigenberger Karin, Einberger Christine, Raderer Markus, Sperr Wolfgang R, Knöbl Paul, Müllauer Leonhard, Uffmann Martin, Dieckmann Karin, Gaiger Alexander and Jäger Ulrich. 20100111. Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. : Annals of hematology.

Harvard

Heintel D., Skrabs C., Hauswirth A., Eigenberger K., Einberger C., Raderer M., Sperr W. R., Knöbl P., Müllauer L., Uffmann M., Dieckmann K., Gaiger A. and Jäger U. (20100111). Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. : Annals of hematology.

MLA

Heintel Daniel, Skrabs Cathrin, Hauswirth Alexander, Eigenberger Karin, Einberger Christine, Raderer Markus, Sperr Wolfgang R, Knöbl Paul, Müllauer Leonhard, Uffmann Martin, Dieckmann Karin, Gaiger Alexander and Jäger Ulrich. Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. : Annals of hematology. 20100111.